Research budgets tighten
Federal funding cuts are starting to bite university and cancer‑centre purchasing as the NIH now caps indirect‑cost reimbursement at 15%, replacing previously higher negotiated rates. Reports cite as much as $2.7 billion impacted and administrative frictions in grant management are already slowing purchase decisions for many labs. (onclive.com; news.research.uci.edu)
University labs and cancer centers are slowing purchases as federal research money gets harder to use and overhead support shrinks. (nih.gov) The National Institutes of Health said on February 7, 2025 that it would set a flat 15% rate for facilities and administrative costs on grants to universities, replacing negotiated rates that often ran far higher. NIH said the old average rate was more than 27%. (nih.gov; statnews.com) Those indirect costs pay for the shared parts of research: lab space, utilities, compliance staff, data systems, biosafety oversight, and other expenses that are not tied to a single experiment. Universities negotiate those rates with the federal government, and many research campuses were above 50% before the NIH notice. (nih.gov; pmc.ncbi.nlm.nih.gov) The policy did not stay in force. On April 4, 2025, U.S. District Judge Angel Kelley issued a permanent injunction blocking NIH from implementing, applying, or enforcing the 15% cap for universities. (aau.edu) Even with the injunction, the disruption is still showing up in research operations. The University of California, Irvine told its research community on February 10, 2025 that the NIH notice applied to new and existing awards, and universities spent weeks preparing for the change while the court fight unfolded. (research.uci.edu; cogr.edu) Cancer centers say the funding swings are hitting both science and patient-facing work. A March 21, 2025 guest essay in The Cancer Letter said grant freezes and indirect-cost cuts were disrupting clinical trials, research staffing, and purchasing at National Cancer Institute-designated centers and academic medical institutions. (cancerletter.com) OncLive reported that estimates from the Senate Health, Education, Labor and Pensions Committee put as much as $2.7 billion in National Institutes of Health research grants at risk in the first three months of 2025. The same report said grant rejections had more than doubled, topping 2,500 applications denied at that point. (onclive.com) University groups argued that a flat 15% rate would shift real operating costs onto campuses, hospitals, and state budgets. NIH said in its February 7 notice that private foundations often pay lower indirect-cost rates and that more money should flow directly to research. (aau.edu; nih.gov) The fight over overhead has widened beyond NIH. The Association of American Universities said the Department of Energy later moved to impose its own 15% cap on indirect costs for university research grants, extending the same budget pressure into other fields. (aau.edu) For labs ordering reagents, replacing microscopes, or hiring grant staff, the immediate issue is less a single line item than whether the institution can still cover the basic cost of running the place where research happens. That question is now moving through courts, agency guidance, and campus budget offices at the same time. (pmc.ncbi.nlm.nih.gov; cogr.edu)
